Spyre Therapeutics Inc (SYRE)

Sales/Maturities of Investments

$109.44M

Quarterly · Period ending: · USD

SYRE logo

SYRE Sales/Maturities of Investments

Latest reported$109.44M
SYRE Quarterly Sales/Maturities of Investments ($0.00 → $109.44M)
High-resolution chart · PNG

SYRE sales/maturities of investments history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Spyre Therapeutics Inc Sales/Maturities of Investments — Quarterly (USD)
Period endingSales/Maturities of Investments (USD)
109,439,000
107,748,000
94,299,000
99,191,000
106,866,000
71,383,000
62,548,000
77,793,000
57,876,000
47,750,000
18,900,000
0
3,250,000
17,750,000
18,500,000
23,750,000
25,000,000
29,296,000
22,913,000
32,120,000
22,000,000
34,000,000
60,620,000
28,850,000
16,064,000
20,142,000
15,750,000
25,875,000
16,250,000
33,804,000
24,750,000
10,750,000
7,085,000
4,785,000
7,035,000
18,160,000
9,570,000
7,440,000
2,680,000
2,000,000
2,016,000
1,750,000
0
0
0
0
0
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.